Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on B-Cell Levels in Infants Exposed to Ocrelizumab During Pregnancy for Mothers with Multiple Sclerosis or Clinically Isolated Syndrome

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Germany Spain
  • Study on the Effects of SAR443820 and Gadobutrol in Patients with Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria France Germany Italy Poland +1
  • Study Comparing Subcutaneous and Intravenous Ocrelizumab for Patients with Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Czechia Italy Poland Spain
  • Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Estonia +14
  • Study on the Effectiveness and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Children with Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated diseases:
    Austria Belgium Croatia Estonia France Germany +7
  • Study Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Bulgaria Croatia Czechia Poland Romania Spain
  • Study on the Safety of Tenofovir Alafenamide and Natalizumab for People with Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated diseases:
    Norway
  • Study on the Safety and Effects of Ocrelizumab for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    2 1 1 1
    Italy Poland
  • Study on the Effectiveness and Safety of Sodium Cromoglicate for Treating Fatigue in Multiple Sclerosis Patients

    Not recruiting

    2 1 1
    Investigated drugs:
    Spain
  • Study on the Effectiveness and Safety of Ocrelizumab, Methylprednisolone, and Diphenhydramine Hydrochloride in Patients with Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Belgium Bulgaria Croatia Denmark France Hungary +8